Compare Albiglutide (evidence A) and Liraglutide (evidence A) on mechanism, clinical status, safety, and dosing.
Albiglutide (brand name Tanzeum in the US, Eperzan in Europe) was a once-weekly GLP-1 receptor agonist consisting of two copies of a modified GLP-1 sequence…
Liraglutide is an FDA-approved GLP-1 receptor agonist with 97% amino acid sequence homology to endogenous human GLP-1. Developed by Novo Nordisk, it is…
Full profiles: Albiglutide, Liraglutide.